Drug Profile
Porcine neural cell product-FE
Alternative Names: Neurocell-FELatest Information Update: 29 Jun 2017
Price :
$50
*
At a glance
- Originator GenVec
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 16 Jun 2017 GenVec was acquired by Intrexon Corporation
- 30 Jul 2004 Discontinued - Phase-I for Epilepsy in USA (Intracerebal)
- 26 Aug 2003 Diacrin has been acquired by, and merged into, GenVec